Dr Chris Eades Consultant physician in infectious diseases and medical mycology

Background

After graduating in medicine from Imperial College School of Medicine (2009), Dr Eades trained in general (internal) medicine in London, becoming a Member of the Royal College of Physicians (UK) in 2013. He then obtained a Master of Science in Infectious Diseases and HIV (2013) from UCL. He then entered higher specialist training in infectious diseases (including HIV medicine) and medical microbiology, gaining Fellowship of the Royal College of Pathologists (medical microbiology by examination) in 2017. He gained mycology experience with a sub-specialty research fellowship split between the National Aspergillosis Centre, Manchester, and The University of Manchester, conducting clinical work alongside a substantial piece of original research. His PhD thesis, for which he is a candidate at the University of Manchester, was titled ‘The Phenomenology of Antimicrobial Use in Haemato-oncology’. During this time, he established a link-service between infectious diseases and the haemato-oncology unit at Manchester Royal Infirmary for the first time.

At the Trust, Dr Eades's clinical work spans clinical and laboratory medicine, including the management of complex bacterial and fungal disease, sepsis and antifungal stewardship.

 

Expertise

Infections (including complex invasive fungal diseases), chronic pulmonary aspergillosis

Research & publications

British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical investigation and management of pyrexia of unknown origin 2023.
van Halsema CL, Eades CP, Johnston VJ, Miller RF.
HIV Med. 2023 Nov;24 Suppl 4:3-18. doi: 10.1111/hiv.13558.

Comparison of β-1-3-D-Glucan and Candida Mannan Biomarker Assays with Serological Tests for the Diagnosis of Candidemia.
Eades CP, Bakri ARBA, Lau JCY, Moore CB, Novak-Frazer L, Richardson MD, Rautemaa-Richardson R.
J Fungi (Basel). 2023 Jul 31;9(8):813. doi: 10.3390/jof9080813.

Aspergillus sensitisation detection using point-of-care lateral flow assay in moderate to severe asthma.
Wang R, Eades C, Palmer M, Platt G, Fowler SJ, Kosmidis C.
Med Mycol. 2023 Aug 2;61(8):myad076. doi: 10.1093/mmy/myad076.

Use of β-D-glucan in diagnosis of suspected Pneumocystis jirovecii pneumonia in adults with HIV infection.
Juniper T, Eades CP, Gil E, Fodder H, Quinn K, Morris-Jones S, Gorton RL, Wey EQ, Post FA, Miller RF.
Int J STD AIDS. 2021 Oct;32(11):1074-1077. doi: 10.1177/09564624211022247. Epub 2021 Jun 9.

Absence of Azole Antifungal Resistance in Aspergillus fumigatus Isolated from Root Vegetables Harvested from UK Arable and Horticultural Soils.
van der Torre MH, Whitby C, Eades CP, Moore CB, Novak-Frazer L, Richardson MD, Rautemaa-Richardson R.
J Fungi (Basel). 2020 Oct 6;6(4):208. doi: 10.3390/jof6040208.

Positive Aspergillus PCR as a marker of azole resistance or sub-therapeutic antifungal therapy in patients with chronic pulmonary aspergillosis.
Moazam S, Eades CP, Muldoon EG, Moore CB, Richardson MD, Rautemaa-Richardson R.
Mycoses. 2020 Apr;63(4):376-381. doi: 10.1111/myc.13052. Epub 2020 Feb 5.